Immunotherapy
12 Sept 2026 · 3 min read

On this page7 sections
Understanding Immunotherapy for Cancer
Immunotherapy is a form of personalised cancer treatment that harnesses the power of the body's natural defense mechanism. Unlike traditional treatments that target cancer cells directly, immunotherapy work by either training the immune system to recognize and destroy cancer cells or boosting its overall efficiency to fight the disease more effectively.
Determining Eligibility for Treatment
Immunotherapy is highly tailored to the individual and the specific characteristics of their cancer. Your oncology team will evaluate several factors to determine if it is appropriate for you:
Tumour biology: Tests checking for specific genetic changes, altered proteins, or chromosomal mutations.
Cancer status: The specific type of cancer and its current stage or spread.
Medical history: Your overall physical health and any previous cancer treatments you have received.
Personal preference: Your informed consent, goals, and personal wishes.
Note: While biomarker testing can indicate a high likelihood of success, it does not guarantee that the treatment will be effective for every patient.
Main Types of Immunotherapy
Different therapies utilize distinct mechanisms to manage cancer, and some may also fall under the category of targeted therapies:
Checkpoint inhibitors: Medications that take the "brakes" off the immune system, allowing it to recognize and attack cancer cells that try to hide.
Monoclonal antibodies (mAbs): Synthetic proteins designed to bind to specific targets on cancer cells, marking them for destruction.
Adoptive cell transfer (e.g., CAR-T therapy): A process where your own T-cells are harvested, genetically modified in a lab to target your specific cancer, and infused back into your body.
Immune system modulators: Subtances that enhance the body’s generalized immune response.
Cancer vaccines: Treatments designed to trigger an immune response against specific cancer-associated antigens.
What to Expect During Treatment
Pre-treatment checks: Routine blood tests and physical assessments are required before beginning therapy to evaluate your baseline health, followed by continuous monitoring during treatment to track your progress.
Administration methods: Depending on the specific drug, immunotherapy can be delivered intravenously, orally, or topically.
Location: Treatment cycles may take place during day visits at an outpatient clinic, during short overnight hospital stays, or occasionally at home.
Duration: The exact schedule, frequency, and total number of treatment cycles vary widely based on how the cancer responds and how well your body tolerates the medicine.
Managing Side Effects and Medication Safety
Because immunotherapy stimulates the immune system, it can cause the body to attack healthy tissues, leading to inflammation in any organ or system.
Timing: Side effects do not always appear immediately. They can develop weeks or even months after your final treatment cycle has concluded.
Drug interactions: Always consult your oncology team before taking any new medications, including prescriptions from your GP, over-the-counter pharmacy products, or herbal supplements, as these can interfere with your therapy or cause dangerous adverse reactions.
Reporting side effects: Patients can log and report suspected adverse reactions directly to regulatory bodies like the Health Products Regulatory Authority at hpra.ie.
Urgent Medical Advice: Contact your care team or your designated emergency medical hotline immediately if you experience new, worsening, or concerning symptoms. For evenings or weekends, utilize your local out-of-hours medical services without delay.
Autonomy and Clinical Trials
The final decision to start, continue, or stop any cancer treatment rests entirely with you. If side effects become difficult to manage, your healthcare team can offer supportive therapies or help you weigh the clinical benefits of continuing versus stopping. Additionally, because personalized oncology is rapidly evolving, you can ask your consultant if you are eligible to join clinical trials investigating new immunotherapy protocols.
Disclaimer
The information provided here is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional or your GP for specific medical concerns, diagnoses, or health advice. Never disregard professional medical advice or delay seeking it because of information you have read here.
